Check out this morning's top movers from around Wall Street, compiled by The Fly. 

HIGHER -

• Novavax (NVAX) up 14% after announcing enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate NVX-CoV2373
• Merck (MRK) up 4% after announcing three scientific initiatives to combat COVID-19: two agreements to develop potential vaccines against SARS-CoV-2 and a research collaboration to advance the development of a novel antiviral candidate
• Argenx (ARGX) up 27% after reporting topline data from the pivotal ADAPT trial of efgartigimod, which met its primary endpoint defined as percentage of responders on the Myasthenia Gravis Activities of Daily Living

UP AFTER EARNINGS -  

• Hibbett Sports (HIBB) up 10%
• American Woodmark (AMWD) up 2%
• Booz Allen (BAH) up 1%
• Magic Software (MGIC) up 5%

DOWN AFTER EARNINGS -  

• Anaplan (PLAN) down 6%

ALSO LOWER -  

• Regeneron (REGN) down 3% after announcing the commencement of an underwritten public secondary offering of its common stock through which Sanofi (SNY) intends to exit its investment in the company's shares
• 1Life Healthcare (ONEM) down 3% after proposing a private offering of $250M of convertible senior notes
• Hertz (HTZ) down 36% after announcing that it and certain of its U.S. and Canadian subsidiaries have filed voluntary petitions for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware